Clinical trials

I like this option because it keeps newsletters from getting lost in the shuffle (or from taking your attention away from more pressing emails) but also keeps them close enough by that you aren’t likely to forget about them. Whenever new newsletters arrive, in fact, you’ll see gentle indications of their presence within your inbox—even though the messages themselves will remain out of the way and detached from everything else. … [Read more...] about Don’t clutter your inbox with newsletters. Use these awesome apps instead

The fact that Trump no longer has access to Twitter should also help matters. The former steak salesman and president can no longer instantly seize control of the national conversation by spreading misinformation or reacting to other news in a way that’s designed to rile up his base. As he demonstrated in his chastened final week in office, without his favorite toy, he has yet to figure out how best to get his every message out into the world with the immediacy and control Twitter provided. … [Read more...] about It’s time to start treating Trump like a fringe cult leader

“With an RNA vaccine, it’s very easy to switch,” says Drew Weissman, an immunologist at the University of Pennsylvania whose early research helped make mRNA vaccines possible. The vaccines contain the genetic instructions for cells in the body to make the spike protein, the part of the virus that invades human cells, helping trigger an immune response so the body is ready to respond if it encounters the actual virus. (Other vaccines, like the one from Johnson & Johnson that is likely to be approved soon, would also be fairly simple to update, though the process would take a few more steps—and thus more time—than the new shots that use mRNA.) … [Read more...] about How easy will it be to update the COVID vaccine if the virus mutates too much?